Author
Listed:
- Liam A. Hurst
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Benjamin J. Dunmore
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Lu Long
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Alexi Crosby
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Rafia Al-Lamki
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- John Deighton
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Mark Southwood
(Papworth Hospital, Papworth Everard)
- Xudong Yang
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Marko Z. Nikolic
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Blanca Herrera
(Facultad de Farmacia, Universidad Complutense. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Calle Del Prof Martin Lagos)
- Gareth J. Inman
(Jacqui Wood Cancer Centre, School of Medicine, University of Dundee, Ninewells Hospital And Medical School)
- John R. Bradley
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Amer A. Rana
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Paul D. Upton
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
- Nicholas W. Morrell
(Box 157, Level 5, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals)
Abstract
Heterozygous germ-line mutations in the bone morphogenetic protein type-II receptor (BMPR-II) gene underlie heritable pulmonary arterial hypertension (HPAH). Although inflammation promotes PAH, the mechanisms by which inflammation and BMPR-II dysfunction conspire to cause disease remain unknown. Here we identify that tumour necrosis factor-α (TNFα) selectively reduces BMPR-II transcription and mediates post-translational BMPR-II cleavage via the sheddases, ADAM10 and ADAM17 in pulmonary artery smooth muscle cells (PASMCs). TNFα-mediated suppression of BMPR-II subverts BMP signalling, leading to BMP6-mediated PASMC proliferation via preferential activation of an ALK2/ACTR-IIA signalling axis. Furthermore, TNFα, via SRC family kinases, increases pro-proliferative NOTCH2 signalling in HPAH PASMCs with reduced BMPR-II expression. We confirm this signalling switch in rodent models of PAH and demonstrate that anti-TNFα immunotherapy reverses disease progression, restoring normal BMP/NOTCH signalling. Collectively, these findings identify mechanisms by which BMP and TNFα signalling contribute to disease, and suggest a tractable approach for therapeutic intervention in PAH.
Suggested Citation
Liam A. Hurst & Benjamin J. Dunmore & Lu Long & Alexi Crosby & Rafia Al-Lamki & John Deighton & Mark Southwood & Xudong Yang & Marko Z. Nikolic & Blanca Herrera & Gareth J. Inman & John R. Bradley & A, 2017.
"TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14079
DOI: 10.1038/ncomms14079
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14079. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.